A Case of ALK-Rearranged Inflammatory Myofibroblastic Tumor of the Bladder with Remarkable Response to ALK Inhibitor

被引：0
|
作者：
Sakai, Yuta [1 ]
Ikawa, Yasuhiro [1 ]
Takenaka, Mika [1 ]
Noguchi, Kazuhiro [1 ]
Fujiki, Toshihiro [1 ]
Kuroda, Rie [1 ]
Nomura, Kozo [2 ]
Sakai, Seisho [2 ]
Wada, Taizo [1 ]
机构：
[1] Kanazawa Univ Hosp, Dept Pediat, Kanazawa, Ishikawa, Japan
[2] Kanazawa Univ Hosp, Dept Pediat Surg, Kanazawa, Ishikawa, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS19-12
引用
收藏
页数：2
相关论文
共 50 条
  • [21] An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor
    Jacob, Sanjivini V.
    Reith, John D.
    Kojima, Angerika Y.
    Williams, William D.
    Liu, Chen
    Duckworth, Lizette Vila
    CASE REPORTS IN PATHOLOGY, 2014, 2014
  • [22] Crizotinib Failure in a TPM4-ALK-Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation
    Tsakiri, Kalliopi
    Kotoula, Vassiliki
    Lakis, Sotirios
    Mueller, Judith
    Fostira, Florentia
    Bobos, Mattheos
    Hytiroglou, Prodromos
    Fountzilas, George
    JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 7
  • [23] A SELECTIVE INHIBITOR SHOWS ANTITUMOR ACTIVITY IN ALK-REARRANGED NSCLC
    不详
    CANCER DISCOVERY, 2013, 3 (06) : 601 - 601
  • [24] Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor
    Park, Sehhoon
    Han, Joungho
    Sun, Jong-Mu
    LUNG CANCER, 2019, 127 : 66 - 68
  • [25] Treatment and detection of ALK-rearranged NSCLC
    Peters, Solange
    Taron, Miguel
    Bubendorf, Lukas
    Blackhall, Fiona
    Stahel, Rolf
    LUNG CANCER, 2013, 81 (02) : 145 - 154
  • [26] CERITINIB IS EFFECTIVE IN ALK-REARRANGED NSCLC
    不详
    CANCER DISCOVERY, 2014, 4 (06) : 632 - 632
  • [27] ALK Amplification in Inflammatory Myofibroblastic Tumor of Bone
    Wang, Kai
    Siegal, Gene
    Guo, Rongjun
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S129 - S129
  • [28] Lorlatinib in ALK-Rearranged Lung Cancer
    Kuang, Shelley
    Leighl, Natasha B.
    CANCER CELL, 2021, 39 (01) : 25 - 27
  • [29] Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung
    Imanishi, Naoko
    Yoneda, Kazue
    Taira, Akihiro
    Ichiki, Yoshinobu
    Sato, Naoko
    Hisaoka, Masanori
    Tanaka, Fumihiro
    SURGICAL CASE REPORTS, 2018, 4
  • [30] Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
    Cai, Weijing
    Lin, Dongmei
    Wu, Chunyan
    Li, Xuefei
    Zhao, Chao
    Zheng, Limou
    Chuai, Shannon
    Fei, Ke
    Zhou, Caicun
    Hirsch, Fred R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3701 - +
12345